Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leon Aarons

Showing results (51-60 of 123) with videos related to

Pageof 13
Sort By:
The AAPS Journal|May 20, 2015
Translating Human Effective Jejunal Intestinal Permeability to Surface-Dependent Intrinsic Permeability: a Pragmatic Method for a More Mechanistic Prediction of Regional Oral Drug AbsorptionAndrés Olivares-Morales, Hans Lennernäs, Leon Aarons, et al.
Journal of Pharmacokinetics and Pharmacodynamics|February 8, 2007
Optimal design for multiresponse pharmacokinetic-pharmacodynamic models - dealing with unbalanced designsKayode Ogungbenro, Ivelina Gueorguieva, Oneeb Majid, et al.
Journal of Pharmacokinetics and Pharmacodynamics|January 10, 2013
The design and analysis of parallel experiments to produce structurally identifiable modelsS Y Amy Cheung, James W T Yates, Leon Aarons
The AAPS Journal|September 16, 2016
Development of a Novel Simplified PBPK Absorption Model to Explain the Higher Relative Bioavailability of the OROS® Formulation of OxybutyninAndrés Olivares-Morales, Avijit Ghosh, Leon Aarons, et al.
Journal of Pharmacokinetics and Pharmacodynamics|November 27, 2009
Ethnic differences in the population pharmacokinetics and pharmacodynamics of warfarinEunice Yuen, Ivelina Gueorguieva, Stephen Wise, et al.
Computer Methods and Programs in Biomedicine|February 13, 2007
A program for individual and population optimal design for univariate and multivariate response pharmacokinetic-pharmacodynamic modelsIvelina Gueorguieva, Kayode Ogungbenro, Gordon Graham, et al.
The Journal of Pharmacy and Pharmacology|October 27, 2016
Forecasting oral absorption across biopharmaceutics classification system classes with physiologically based pharmacokinetic modelsSimone Hansmann, Adam Darwich, Alison Margolskee, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 13, 2023
Towards a population pharmacokinetic/pharmacodynamic model of anti-VEGF therapy in patients with age-related macular degenerationEva M Del Amo, Paul N Bishop, Pere Godia, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 17, 2023
A "middle-out approach" for the prediction of human drug disposition from preclinical data using simplified physiologically based pharmacokinetic (PBPK) modelsEstelle Yau, Michael Gertz, Kayode Ogungbenro, et al.
British Journal of Clinical Pharmacology|July 17, 2021
Evaluation of area under the concentration curve adjusted by the terminal-phase as a metric to reduce the impact of variability in bioequivalence testingAdam J Lucas, Kayode Ogungbenro, Shuying Yang, et al.
Pageof 13

Showing results (51-60 of 123) with videos related to

Sort By:
Pageof 13
The AAPS Journal|May 20, 2015
Translating Human Effective Jejunal Intestinal Permeability to Surface-Dependent Intrinsic Permeability: a Pragmatic Method for a More Mechanistic Prediction of Regional Oral Drug AbsorptionAndrés Olivares-Morales, Hans Lennernäs, Leon Aarons, et al.
Journal of Pharmacokinetics and Pharmacodynamics|February 8, 2007
Optimal design for multiresponse pharmacokinetic-pharmacodynamic models - dealing with unbalanced designsKayode Ogungbenro, Ivelina Gueorguieva, Oneeb Majid, et al.
Journal of Pharmacokinetics and Pharmacodynamics|January 10, 2013
The design and analysis of parallel experiments to produce structurally identifiable modelsS Y Amy Cheung, James W T Yates, Leon Aarons
The AAPS Journal|September 16, 2016
Development of a Novel Simplified PBPK Absorption Model to Explain the Higher Relative Bioavailability of the OROS® Formulation of OxybutyninAndrés Olivares-Morales, Avijit Ghosh, Leon Aarons, et al.
Journal of Pharmacokinetics and Pharmacodynamics|November 27, 2009
Ethnic differences in the population pharmacokinetics and pharmacodynamics of warfarinEunice Yuen, Ivelina Gueorguieva, Stephen Wise, et al.
Computer Methods and Programs in Biomedicine|February 13, 2007
A program for individual and population optimal design for univariate and multivariate response pharmacokinetic-pharmacodynamic modelsIvelina Gueorguieva, Kayode Ogungbenro, Gordon Graham, et al.
The Journal of Pharmacy and Pharmacology|October 27, 2016
Forecasting oral absorption across biopharmaceutics classification system classes with physiologically based pharmacokinetic modelsSimone Hansmann, Adam Darwich, Alison Margolskee, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 13, 2023
Towards a population pharmacokinetic/pharmacodynamic model of anti-VEGF therapy in patients with age-related macular degenerationEva M Del Amo, Paul N Bishop, Pere Godia, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 17, 2023
A "middle-out approach" for the prediction of human drug disposition from preclinical data using simplified physiologically based pharmacokinetic (PBPK) modelsEstelle Yau, Michael Gertz, Kayode Ogungbenro, et al.
British Journal of Clinical Pharmacology|July 17, 2021
Evaluation of area under the concentration curve adjusted by the terminal-phase as a metric to reduce the impact of variability in bioequivalence testingAdam J Lucas, Kayode Ogungbenro, Shuying Yang, et al.
Pageof 13